NL-OMON51129CompletedNot Applicable
Cardionomic Cardiac Pulmonary Nerve Stimulation Pilot Study - CPNS Pilot Study
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Cardionomic Inc
- Enrollment
- 10
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Subjects must meet all the following inclusion criteria to be eligible to
- •participate in this study:
- •1. At least 18 years of age, or older if required by local law
- •2. Admitted to the hospital with a principal diagnosis of acute decompensated
- •heart failure.
- •3. BMI adjusted BNP >= 500 pg/mL or NT-pro-BNP >= 2000 pg/mL; 4% reduction in
- •BNP/NT-proBNP for every increase of 1 kg/m2 in BMI above a reference of 20kg/m2
- •(Refer to Appendix B: BNP/NT-proBNP corrected for BMI)
- •4. Left ventricular ejection fraction <= 45%; documented within previous 12
- •5. At least one sign or symptom of fluid overload
- •6. At least one of the following:
- •o Persistent inadequate diuretic response
- •o At least one sign or symptom of low perfusion
Exclusion Criteria
- •1. First IV treatment upon presentation in hospital to randomization is > 48
- •2. Received an inotrope during current hospitalization or anticipated to
- •receive an inotrope in the 12 hours following enrollment
- •3. Requires mechanical support (e.g., mechanical circulatory support,
- •ultrafiltration) or anticipated to receive mechanical support in the 12 hours
- •following enrollment
- •4. Manually measured systolic blood pressure < 80 mmHg at screening
- •5. Manually measured systolic blood pressure > 130 mmHg at screening
- •6. Symptomatic hypotension
- •7. eGFR < 25 mL/min/1.73m2
- •8. Has an active infection
- •9. Has an active or passive implantable device that may interfere with CPNS
- •therapy per physician discretion
- •10. Has a cardiac resynchronization therapy (CRT) device or a pacemaker
- •11. Has an implantable cardioverter defibrillator (ICD) and is pacemaker
- •dependent or has had a sustained VT/VF episode in the previous 90 days (a
- •subject can be enrolled if he/she meets this criterion, the physician deems it
- •appropriate to suspend therapies during hospitalization and leads have been
- •implanted for at least six months prior to the study procedure) 12. Permanent
- •or persistent atrial fibrillation with uncontrolled ventricular response
- •(ventricular rate > 125 BPM) at time of enrollment
- •13. Unstable angina or documented myocardial infarction within last 30 days
- •14. Prior heart transplant
- •15. History of severe mitral or aortic stenosis or regurgitation
- •16. History of pulmonary embolism within the last 6 months
- •17. History of hyper-coagulation disorders
- •18. History of more than one CABG procedure
- •19. History of severe pulmonary hypertension (pulmonary arterial systolic
- •pressure >= 75 mmHg)
- •20. Diagnosis of primary pulmonary hypertension
- •21. Diagnosis of congenital heart disease
- •22. Participating in concurrent trial unless approved by Cardionomic study
- •23. Pregnant or childbearing age and not on reliable form of birth control
- •24. Allergy to nickel, fentanyl, midazolam, propofol, heparin, eggs, egg
- •products, soybeans or soy products
- •25. Unwilling or unable to provide consent
- •26. Exclusion criteria by local law (e.g., age, prisoner, etc)
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Effects of Physical Exercise on post-discharge patients by Covid-19RBR-5n53cnvHospital Militar de Área de São Paulo
Active, not recruiting
Not Applicable
Assessment of muscle electrical activity during Cardiopulmonary TestingObesityRBR-2y6fv92Centro Universitário da Paraíba (UNIESP)
Completed
Phase 4
Evaluation of Cardiac Sympathetic Nerve Activity and Aldosterone Suppression in Patients With Decompensated Acute Heart Failure on the Treatment Containing Intravenous Atrial Natriuretic Peptidedecompensated acute heart failureJPRN-UMIN000009170Kitakanto Cardiovascular Hospital200
Completed
Not Applicable
Transcutaneous Electrical Nerve Stimulation and Cardiac Sympathetic Overdrive in Heart FailureCardiovascular AbnormalitiesNCT03354689Universidade Federal Fluminense17
Completed
Not Applicable
Physiotherapy chest exercises and Positioning use in Ventilated Neonates.CTRI/2016/04/006831College of Physiotherapy Padamashree Dr Vittalrao Vikhe Patil Foundation Ahmednagar82
